Value Investor
Start free

CVRx

CVRX on Nasdaq. Market value $42m.

Watch this stockFree. We tell you when something changes.

Should I look at this?

We have not checked this company yet

This is not advice.

Compare with another stock

Who owns it

None of the long-term investors we follow own it. 88 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

4 investors own more than 5%.

  • JOHNSON & JOHNSON
    Passive investor
    at least 15.4%
    (filed with 1 related holder)
    Since 31 December 2025
  • New Enterprise Associates 10, Limited Partnership
    Passive investor
    at least 7.8%
    (filed with 7 related holders)
    Since 18 February 2025
    What they said

    Not applicable.

    Read the filing
  • Kirk Nielsen
    Passive investor
    at least 7.2%
    (filed with 3 related holders)
    Since 31 December 2024
  • Cooperatieve Gilde Healthcare IV U.A.
    Passive investor
    at least 4.9%
    (filed with 4 related holders)
    Since 4 February 2025
  • Chernett Jorey
    Activist
    Wants the company sold
    Sold down below 5%
    Since 30 September 2026
    What they said

    Item 4 is hereby amended to add the following: This Amendment No. 1 is being filed to report that, following a difference of opinion with the Issuer's management regarding the Issuer's strategic direction, the Reporting Person has sold Shares and, as a result, no longer…

    Read the filing

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 2 insiders bought $376,864 of shares on the open market. 6 sold $129,873, $129,873 of it under preset trading plans.

  • Binkowski Brent
    CHIEF OPERATING OFFICER
    Bought
    Date
    13 August 2026
    Shares
    26,223
    Price
    $2.91
    Value
    $76,432
  • Binkowski Brent
    CHIEF OPERATING OFFICER
    Sold
    under a preset trading plan
    Date
    12 August 2026
    Shares
    1,309
    Price
    $2.55
    Value
    $3,338
  • Adamson Philip B.
    Chief Medical Officer
    Sold
    under a preset trading plan
    Date
    2 March 2026
    Shares
    1,262
    Price
    $7.90
    Value
    $9,970
  • John Robert Allen
    Chief Revenue Officer
    Sold
    under a preset trading plan
    Date
    2 March 2026
    Shares
    3,964
    Price
    $7.90
    Value
    $31,316
  • VERRASTRO PAUL
    CHIEF MKTG & STRAT OFFICER
    Sold
    under a preset trading plan
    Date
    2 March 2026
    Shares
    1,284
    Price
    $7.90
    Value
    $10,144
  • OASHEIM JARED
    CHIEF FINANCIAL OFFICER
    Sold
    under a preset trading plan
    Date
    2 March 2026
    Shares
    1,744
    Price
    $7.90
    Value
    $13,778
  • Hykes Kevin
    PRES & CEO, Director
    Sold
    under a preset trading plan
    Date
    2 March 2026
    Shares
    7,763
    Price
    $7.90
    Value
    $61,328
  • Jain Mudit K.
    Director
    Bought
    Date
    20 February 2026
    Shares
    46,800
    Price
    $6.36
    Value
    $297,648
  • Jain Mudit K.
    Director
    Bought
    Date
    18 February 2026
    Shares
    600
    Price
    $4.64
    Value
    $2,784

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 13 Feb 2026, plus the 10-Q filed 6 Aug 2026 and 8 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from

A big holder just moved. The deep dive shows what the business is worth.

Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.